amiloride has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conway, SJ; Ganapathy, ME; Ganapathy, V; Huang, W; Kekuda, R; Leibach, FH; Wang, H; Wu, X | 1 |
| Le Couteur, DG; McLean, AJ; Yang, MC | 1 |
| Albinson, K; Arias, RL; Beyer, C; Bowlby, MR; Dunlop, J; Dwyer, JM; Kagan, N; Kubek, K; Lin, Q; Monaghan, M; Sung, ML; Vasylyev, D; Zaleska, MM; Zhang, MY | 1 |
3 other study(ies) available for amiloride and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Amiloride; Animals; Binding, Competitive; Carbon Radioisotopes; Cations; Cloning, Molecular; DNA-Binding Proteins; DNA, Complementary; Dopamine Agents; Exons; Gene Expression Regulation; HeLa Cells; Herbicides; Humans; In Situ Hybridization; Introns; Kidney; Mice; Niacinamide; Octamer Transcription Factor-3; Oocytes; Pigment Epithelium of Eye; RNA, Messenger; Tetraethylammonium; Transcription Factors; Tritium; Xenopus laevis | 2000 |
Cell membrane transport of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the liver and systemic bioavailability.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amiloride; Animals; Biological Availability; Biological Transport, Active; Cell Membrane; Daunorubicin; Hepatocytes; In Vitro Techniques; Liver; Male; MPTP Poisoning; Neurotoxins; Organic Cation Transporter 1; Perfusion; Rats; Rats, Wistar; Rifamycins; Tubocurarine | 2001 |
Amiloride is neuroprotective in an MPTP model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acid Sensing Ion Channels; Acidosis, Lactic; Amiloride; Animals; Antiparkinson Agents; Binding, Competitive; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Peptides; Radioligand Assay; Sodium Channel Blockers; Sodium Channels; Spider Venoms; Substantia Nigra; Tyrosine 3-Monooxygenase | 2008 |